Health Care Equipment & Services

CVS Health’s latest share‑transfer filing and America250 partnership reveal how transparent governance, community branding, and tech‑driven PBM strategies keep it ahead in the U.S. pharmacy‑benefits race.

Q1 2026 sees X Bioscience’s operating loss spike to THB 245 m as admin costs rise and goodwill impairments hit THB 120 m. The company counters with a central‑kitchen plan, a new dim‑sum venture, and tight capital controls, aiming to slash unit costs…

Fisher & Paykel Healthcare declares a 30% dividend, revealing strong cash flow and growth while backing next‑gen medical devices and patient‑centric care.

Humm Group’s board seat remains vacant as ASIC completes investigations, highlighting the firm’s focus on AI governance, breach protocols, and fair loan terms.

Pro Medic Ltd. attracts tech‑savvy investors and clinical users alike—its diagnostics software boosts accuracy, safety, and workflow while driving strong ASX momentum.

Elevance Health (ELV) completes a $4.80‑exercise‑price, cash‑free tranche of 5 + million options, expanding equity while keeping its capital base steady.

UnitedHealth Group’s Q2 earnings outlook shows a 5‑7 pp Medicare Advantage margin boost, $80 M PPO savings, and AI‑driven OptumHealth gains—boosting net earnings while navigating PBM risk.

Fresenius Medical Care AG shares its 2025 401(k) audit, a 2‑million share buyback, and market outlook, highlighting strong employee benefits and shareholder value creation.

Alcidion Group’s AI‑driven Miya Precision platform powers interoperable health‑IT across ANZ, UK, NZ, and beyond—backed by debt‑free, high‑margin contracts and a global investor roadshow.

Discover how Cigna Group’s 2025 results show resilience, with palm oil price gains and a cashew turnaround, driving future growth and shareholder value.